Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of SCG5 mRNA | decreases expression | 18648102
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SCG5 mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of SCG5 mRNA | increases expression | 20106945
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide affects the expression of SCG5 mRNA | affects expression | 20382639
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of SCG5 mRNA | increases expression | 15336504
|
D016572 |
Cyclosporine |
Cyclosporine results in increased expression of SCG5 mRNA | increases expression | 20106945
|
C014347 |
decitabine |
decitabine results in increased expression of SCG5 mRNA | increases expression | 17334394
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of SCG5 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in decreased expression of SCG5 mRNA | decreases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of SCG5 mRNA | affects cotreatment|decreases expression | 17942748
|
D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of SCG5 mRNA | increases expression | 16807920
|
D016685 |
Mitomycin |
SCG5 protein affects the susceptibility to Mitomycin | affects response to substance | 16217747
|
D017239 |
Paclitaxel |
SCG5 protein affects the susceptibility to Paclitaxel | affects response to substance | 16217747
|
D017239 |
Paclitaxel |
Paclitaxel results in increased expression of SCG5 mRNA | increases expression | 15585946
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SCG5 mRNA | affects binding|decreases expression|increases activity | 19710929
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of SCG5 mRNA | affects expression | 17555576
|
D013654 |
Taurine |
Taurine results in increased expression of SCG5 mRNA | increases expression | 16579726
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin affects the expression of SCG5 mRNA | affects expression | 16611356
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of SCG5 mRNA | affects cotreatment|decreases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SCG5 mRNA | decreases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.61 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.90 | 11752688 14514962 15322242 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.61 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.00 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.15 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.20 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
4.20 | 14692618 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
6.65 | 3712494 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
6.65 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.07 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.07 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.97 | 11748828 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.12 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.51 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.68 | 15885639 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.08 | 11289319 1440618 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.86 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.86 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.85 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.78 | 15746008 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.60 | 15867366 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
2.35 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
2.35 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
2.35 | 18323546 15136595 18223236 16273361 11325840 16244791 16115903 18234424 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
2.35 | 17893378 20859285 19066611 19487384 18997820 19410462 11161223 19200415 19011961 19189210 20135344 18984771 18629630 17440819 20065188 17049068 18821012 19103187 18351453 20005174 19244106 19189212 17242785 19115204 19059307 16873071 16818667 20544844 18815881 21138602 19221464 19288272 15668708 21152245 19142967 19289846 18425577 15565566 18855134 17261762 19084267 20390343 16202921 19155303 16273361 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.35 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.82 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.55 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
4.69 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
4.69 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
4.69 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.69 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.70 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
4.70 | 19215824 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.64 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.38 | 18670907 16120746 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
11.25 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.25 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
11.25 | 12371664 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.19 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
19.39 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
19.39 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
19.39 | 17681005 17333356 16105132 17110522 15861022 16919318 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
19.39 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.11 | 16354765 15340226 15668235 8697196 12621046 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.34 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
marker/mechanism |
|
| 18084292 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.80 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
2.80 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.08 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.25 | 15322242 20055451 10048152 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.40 | 19031437 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.84 | 8156756 11298694 2524372 11906362 12868966 8970840 18759878 14531868 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.44 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.52 | 2952479 3621924 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.67 | 17107852 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Taurine |
6.10 | 16025228 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.50 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
6.43 | 1440618 9653073 9328219 18289764 8291058 16192314 7440962 11289319 18648102 18692083 6482804 9022650 6679447 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Taurine |
6.43 | 9328219 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.43 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.78 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
6.63 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
6.63 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.96 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.07 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
9.07 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.18 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.06 | 19155303 20544844 16202921 17893378 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.05 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
10.47 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
10.47 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
10.47 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
10.47 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.03 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
18.99 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
18.99 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
18.99 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
18.99 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.25 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.50 | 11858732 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.08 | 6705139 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.58 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.23 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.62 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.62 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.27 | 8708960 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.07 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.66 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.50 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
6.49 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.49 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.55 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.47 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.36 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.55 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.40 | 18467677 19772884 16221962 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.40 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.11 | 8697196 18606429 16354765 16959395 15340226 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.21 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.98 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
4.98 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
4.98 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.85 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.49 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
6.78 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.78 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
4.93 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.93 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.65 | 16306350 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.08 | 8074119 9022650 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.36 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.50 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.35 | 8314463 10903974 18776723 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.51 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
12.51 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
12.51 | 18625569 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.08 | 18980019 19235587 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.03 | 19117987 17236224 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.38 | 18704418 18460780 18206229 17679729 19387464 19010910 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.52 | 18055864 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.17 | 15342952 17567588 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.85 | 17353645 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.21 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
5.02 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
5.02 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Taurine |
5.02 | 15931870 15893842 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
5.02 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
14.36 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Mitomycin |
14.36 | 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
14.36 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
14.36 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
14.36 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
5.78 | 3712494 6587162 598648 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.78 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
3.36 | 20869020 17053015 6695378 18520028 20135361 20464547 20064080 18816296 18569708 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
3.36 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.36 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.44 | 19470736 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
4.11 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.81 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.64 | 14580682 11731420 16827153 19196723 19196722 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.61 | 19453300 |
MESH:D008527 |
Medulloblastoma |
marker/mechanism |
|
| 17334394 |
MESH:D008545 |
Melanoma |
|
decitabine |
5.24 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
5.24 | 12025231 12040289 16342250 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
5.24 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.23 | 15990972 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.85 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.21 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
7.66 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
7.66 | 14749477 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.55 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.40 | 19157545 19010910 16882708 18608210 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.15 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.04 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.97 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
9.62 | 3581430 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
9.62 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
9.62 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.52 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.31 | 11141357 |
MESH:D009369 |
Neoplasms |
|
decitabine |
8.31 | 19470736 17925555 19116145 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.31 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.06 | 19189210 19196722 19200415 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.50 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.31 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.25 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
2.93 | 6679447 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.45 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.08 | 3988306 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
5.03 | 15867366 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
5.23 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
5.23 | 11161223 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
5.77 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Mitomycin |
5.77 | 15113037 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.72 | 11578682 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.52 | 7296757 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.31 | 12520081 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.53 | 6228378 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.59 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.25 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.24 | 11896295 11222880 11399792 11118676 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
4.77 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.60 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
2.60 | 17136230 16356831 16729912 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.60 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.36 | 15861022 16919318 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.40 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.87 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.39 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.43 | 19155313 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.47 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
9.47 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.47 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
11.77 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
11.77 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.09 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
3.47 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
3.47 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
3.47 | 18506536 18396642 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.86 | 16930453 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.65 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.18 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.96 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.32 | 6582329 7505956 6587162 3712494 1399818 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
7.32 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
12.02 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
12.02 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
12.02 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
12.02 | 17572228 8653321 16712894 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.33 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.98 | 17785578 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.05 | 1336536 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.66 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.57 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.31 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.50 | 17120751 |